CLINICAL_TRIALS
trial_result
· 2014-01-31
Clinical Trial Update: Efficacy of YKP3089 in Patients With Photosensitive Epilepsy [Phase 2]
Summary
This update reports the completion of a Phase 2 trial evaluating the efficacy of YKP3089 in patients with photosensitive epilepsy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SK Life Science, Inc. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED